Dopey-2 Inhibitors is a chemical class of compounds primarily designed for research purposes, with a focus on inhibiting the Dopey-2 protein. These inhibitors belong to the broader category of small molecules and are specifically tailored to interact with the Dopey-2 protein in various experimental contexts. Dopey-2, a protein of interest in scientific investigations, is the target of these inhibitors, and they play a crucial role in elucidating its function and regulatory mechanisms. In scientific inquiry, the process of inhibitor identification is systematic and evidence-based. It involves the discovery or design of molecules that can bind to a protein and reduce its activity. These inhibitors can be identified through methods such as high-throughput screening, where large libraries of chemicals are tested for their ability to interfere with the protein's function. Once candidate inhibitors are found, their interactions with the protein are studied in detail using techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to understand how they inhibit protein function.
The chemical properties and structures of Dopey-2 inhibitors can vary significantly, as they are synthesized to specifically interact with the unique binding sites or functional domains of the Dopey-2 protein. Researchers employ these inhibitors to modulate the activity of Dopey-2 in vitro and in cellular studies, enabling a deeper understanding of its physiological role and molecular interactions. These inhibitors are valuable tools in biochemical and cell biology research, allowing scientists to investigate the downstream effects of Dopey-2 inhibition, explore pathways influenced by its activity, and uncover its role in cellular processes. By providing a means to selectively manipulate Dopey-2, these inhibitors contribute to the advancement of scientific knowledge in the field of molecular biology and cellular signaling, ultimately expanding our understanding of the intricate mechanisms governing cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
This compound acts as a broad-spectrum protein kinase inhibitor, directly inhibiting Dopey-2 by blocking its kinase activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As an inhibitor of phosphoinositide 3-kinases (PI3Ks), this compound indirectly inhibits Dopey-2 by disrupting downstream signaling pathways crucial for its activation and function. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
By inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, this compound leads to inhibition of downstream signaling cascades that regulate Dopey-2 expression and activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Acting as an inhibitor of tyrosine kinases, including those involved in the regulation of Dopey-2 signaling pathways, this compound inhibits its activity indirectly by disrupting upstream signaling events. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an immunosuppressive agent that inhibits mTOR (mammalian target of rapamycin), this compound inhibits Dopey-2 activity by interfering with mTOR-mediated signaling pathways crucial for its regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Specifically inhibiting p38 mitogen-activated protein kinase (MAPK), this compound indirectly inhibits Dopey-2 activity by disrupting downstream signaling cascades essential for its function. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Acting as a dual Src and Bcr-Abl tyrosine kinase inhibitor, this compound indirectly inhibits Dopey-2 activity by disrupting signaling pathways upstream of its activation. | ||||||